- Conference
- November 2025
- 2 Days
Global
€1605EUR$1,740USD£1,299GBP
€1852EUR$2,008USD£1,499GBP
- Conference
- July 2025
- 2 Days
Global
€1605EUR$1,740USD£1,299GBP
€1852EUR$2,008USD£1,499GBP
- Conference
- March 2025
- 2 Days
Global
€1852EUR$2,008USD£1,499GBP
- Training
- February 2023
- 6 Hours
Global
From €933EUR$978USD£782GBP
- Training
- May 2023
- 3 Days
Global
From €2226EUR$2,332USD£1,865GBP
- Training
- April 2023
- 3 Hours
Global
From €1168EUR$1,224USD£979GBP
- Training
- January 2025
- 2 Days
Global
From €759EUR$795USD£636GBP
- Training
- September 2023
- 3 Days
Global
From €2768EUR$2,900USD£2,319GBP
- Training
- March 2023
- 3 Hours
Global
From €1168EUR$1,224USD£979GBP
- Webinar
- March 2023
- 90 Minutes
Global
From €458EUR$480USD£384GBP
- Training
- March 2023
- 3 Days
Global
€2226EUR$2,332USD£1,865GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 8 Hours
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
The Master Verification and Validation (MV&V) market within the context of Pharmaceutical Manufacturing is a specialized field that focuses on the quality assurance of pharmaceutical products. It involves the use of a variety of techniques to ensure that the product meets the required standards of safety, efficacy, and quality. This includes the use of analytical methods, such as chromatography and spectroscopy, to analyze the composition of the product, as well as the use of physical and chemical tests to assess the product's stability and shelf life. Additionally, MV&V also involves the use of risk management techniques to identify and mitigate potential risks associated with the product.
Some of the companies in the MV&V market include Merck, Pfizer, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more
